- Report
- January 2024
- 276 Pages
Global
From €2548EUR$2,800USD£2,185GBP
€3640EUR$4,000USD£3,121GBP
- Report
- March 2022
- 82 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- February 2021
- 95 Pages
Europe
From €4505EUR$4,950USD£3,862GBP
- Report
- April 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 118 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 120 Pages
Europe
From €4323EUR$4,750USD£3,706GBP
- Report
- October 2023
- 140 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- September 2023
- 140 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- November 2023
- 80 Pages
France
From €3185EUR$3,500USD£2,731GBP
- Report
- November 2023
- 178 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2023
- 181 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 90 Pages
India
From €3185EUR$3,500USD£2,731GBP
- Report
- October 2023
- 172 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- April 2023
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2022
- 31 Pages
Global
From €633EUR$695USD£542GBP
- Report
- June 2022
- 16 Pages
Global
From €1775EUR$1,950USD£1,521GBP

The Real World Evidence (RWE) market within the context of E-Healthcare is a rapidly growing sector. It is a form of evidence-based medicine that uses data from real-world sources such as patient records, claims data, and observational studies to inform healthcare decisions. RWE can be used to assess the safety and effectiveness of treatments, identify new indications for existing treatments, and inform healthcare policy. It can also be used to assess the cost-effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
RWE is increasingly being used by healthcare providers, payers, and pharmaceutical companies to inform their decisions. It is also being used by researchers to gain insights into the effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
Some companies in the RWE market include IBM Watson Health, Optum, Flatiron Health, and Evidation Health. Show Less Read more